MIRM · Mirum Pharmaceuticals, Inc.

$100.64 +1.87 (+1.89%) At close · Aug 14

Market Cap

$6.53B

64.93M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Peetz	Chief Executive Officer	$755,000	—	$3,683,904	$4,931,320	$1,057,000	$14,000	$10,441,224
Peter Radovich	President and Chief Operating Officer	$572,500	—	$1,199,500	$1,605,770	$572,500	$14,000	$3,964,270
Joanne Quan	Chief Medical Officer	$520,000	—	$959,600	$1,284,616	$468,000	$14,000	$3,246,216
Eric Bjerkholt	Chief Financial Officer	$520,000	—	$959,600	$1,284,616	$468,000	$14,000	$3,246,216

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Peetz	Chief Executive Officer	$730,000	—	$2,218,206	$2,844,495	$792,050	$13,800	$6,598,551
Joanne Quan	Chief Medical Officer	$479,167	—	$1,328,622	$1,433,288	$334,457	$13,800	$3,589,334
Peter Radovich	President and Chief Operating Officer	$550,000	—	$1,020,375	$1,327,431	$426,250	$13,800	$3,337,856
Eric Bjerkholt	Chief Financial Officer	$500,000	—	$538,542	$606,826	$348,750	$12,137	$2,006,255

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Peetz	Chief Executive Officer	$660,000	—	$1,761,000	$3,383,920	$633,600	$13,200	$6,451,720
Eric Bjerkholt	Chief Financial Officer	$151,562	—	$1,673,650	$2,417,470	$95,246	—	$4,337,928
Peter Radovich	President and Chief Operating Officer	$505,000	—	$508,577	$977,107	$363,600	$13,200	$2,367,484
Joanne Quan	Chief Medical Officer	—	—	—	—	—	—	—

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Peetz	Chief Executive Officer	$624,000	—	$634,800	$2,682,384	$449,280	$12,200	$4,402,664
Peter Radovich	President and Chief Operating Officer	$467,500	—	$158,700	$670,596	$252,450	$12,200	$1,561,446
Pamela Vig	Head of Research and Development	$450,000	—	$158,700	$670,596	$216,000	$12,200	$1,507,496
Lara Longpre	Chief Development Officer	$450,000	—	$158,700	$670,596	$216,000	$12,200	$1,507,496
Eric Bjerkholt	Chief Financial Officer	—	—	—	—	—	—	—
Joanne Quan	Chief Medical Officer	—	—	—	—	—	—	—

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Peetz	President and Chief Executive Officer	$600,000	—	$559,781	$2,546,950	$412,500	$11,600	$4,130,831
Ian Clements Ph.D	Chief Financial Officer	$425,000	—	$239,906	$1,091,550	$212,500	$11,600	$1,980,556
Edwin Tucker M.D	Former Chief Medical Officer	$383,075	—	$207,919	$946,010	—	$418,717	$1,955,721
Peter Radovich	Chief Operating Officer	$425,000	—	$207,919	$946,010	$212,500	$11,600	$1,803,029

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Peetz	President and Chief Executive Officer	$511,818	—	—	$2,218,755	$265,952	$7,453	$3,003,978
Peter Radovich	Chief Operating Officer	$277,992	—	—	$2,255,631	$111,197	—	$2,644,820
Ian Clements	Chief Financial Officer	$378,390	$151,356	—	$848,348	—	$11,400	$1,389,494
Ian Clements Ph.D	Chief Financial Officer	$378,390	—	—	$848,348	$151,356	$11,400	$1,389,494

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Peetz	Chief Executive Officer and President	$457,614	$286,100	—	$5,491,471	—	—	$6,235,185
Michael Grey	Former Executive Chairman and Chief Executive Officer	$300,000	$150,000	—	$5,212,396	—	—	$5,662,396
Pamela Vig	Chief Scientific Officer	$354,826	$155,300	—	$2,171,832	—	—	$2,681,958
Lara Longpre	Chief Development Officer	$354,826	$155,300	—	$2,171,832	—	—	$2,526,658

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Peetz	Chief Executive Officer and President	$32,083	—	—	—	—	—	$32,083
Lara Longpre	Chief Development Officer	$27,500	—	—	—	—	—	$27,500
Pamela Vig	Chief Scientific Officer	$27,500	—	—	—	—	—	$27,500
Michael Grey	Former Executive Chairman and Chief Executive Officer	$25,000	—	—	—	—	—	$25,000

Executive changes

Person	Role	Change	Effective	Filed
Peter Radovich	President	Appointed	2024-01-16	2024-01-16
Eric Bjerkholt	Chief Financial Officer	Appointed	2023-09-11	2023-09-11
Timothy Walbert	Class I director	Appointed	2023-04-05	2023-04-06
Ian Clements, Ph.D.	Chief Financial Officer	Resigned	2023-05-15	2023-01-09
Lon Cardon, Ph.D., FMedSci	Class I director	Appointed	2022-12-19	2022-12-19
Carol L. Brosgart, M.D.	director	Resigned	2022-12-19	2022-12-19
Edward T. Mathers	director	Resigned	2022-09-01	2022-09-02
Saira Ramasastry	Class II director	Appointed	2022-06-02	2022-06-06

Key facts CIK 1759425 CUSIP 604749101 13F (30d) 318 filings 312 filers Visit website Investor relations